An improved algorithm to screen for carbapenemase production in <i>Pseudomonas aeruginosa</i>. [PDF]
JAC Antimicrob ResistEllem JA +4 more
europepmc +1 more source
Synergy of lytic phage pB23 and meropenem combination against carbapenem-resistant Acinetobacter baumannii [PDF]
Jun Luo +8 more
openalex +1 more source
Prevalence of ESBL-producing Escherichia coli from different canine populations in Italy [PDF]
, 2016 DOTTO, GIORGIA +5 more
core +1 more source
Extensive hidradenitis suppurativa (HS) Hurly stage III disease treated with intravenous (IV) linezolid and meropenem with rapid remission [PDF]
, 2015 Noah Scheinfeld
openalex +1 more source
Reply to Gatti and Pea, “Are the pharmacokinetic data of meropenem studied in CSF of a mixed population composed of patients with cerebral infections and patients with extracerebral infections really helpful for clinicians treating CNS infections?” [PDF]
Sebastian G. Wicha +15 more
openalex +1 more source
Evaluation of Meropenem Regimens Suppressing Emergence of Resistance in Acinetobacter baumannii with Human Simulated Exposure in an In Vitro Intravenous-Infusion Hollow-Fiber Infection Model [PDF]
, 2014 Xin Li +7 more
openalex +1 more source
From bugs to bots: learning infectious diseases in the AI era. [PDF]
Antimicrob Steward Healthc EpidemiolRodriguez-Nava G.
europepmc +1 more source
Quantitation of antibiotics in exhaled breath : a pilot study (ANTIBEX-trial) [PDF]
, 2018 Carlier, Mieke +5 more
core
Can a population pharmacokinetics model built on intermittent infusions accurately predict meropenem concentrations in children receiving continuous infusions? [PDF]
Br J Clin PharmacolCheng L +5 more
europepmc +1 more source